Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details)

v3.22.4
Related Party Transactions (Details) - Affiliated Entity - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
May 22, 2021
May 22, 2020
Line of Credit          
Related Party Transaction [Line Items]          
Line of credit facility maximum borrowing capacity       $ 15.0 $ 15.0
Long term debt outstanding $ 0.0        
Strategic Alliance With Inivata Limited          
Related Party Transaction [Line Items]          
Related party transaction, expenses from transactions with related party   $ 0.8      
Pharma Service Contracts with CytomX Therapeutics, Inc.          
Related Party Transaction [Line Items]          
Revenue from Related Parties 0.7 0.7 $ 0.3    
Pharma Services contracts with HOOKIPA Pharma, Inc          
Related Party Transaction [Line Items]          
Revenue from Related Parties $ 0.4 $ 0.5